TherapeuticsMD, Inc. (TXMD)
2.14
+0.04
(+1.90%)
USD |
NASDAQ |
Jan 14, 16:00
2.12
-0.02
(-0.93%)
After-Hours: 20:00
TherapeuticsMD Market Cap: 24.77M for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.14B |
| Eli Lilly & Co. | 960.61B |
| Pfizer Inc. | 145.44B |
| AbbVie, Inc. | 392.16B |
| NovaBay Pharmaceuticals, Inc. | 1.604B |
Market Cap Related Metrics
| PE Ratio | 82.31 |
| PS Ratio | 8.846 |
| Price to Book Value | 0.9025 |
| Price to Free Cash Flow | 11.96 |
| Price | 2.14 |
| Earnings Yield | 1.22% |
| Normalized PE Ratio | 63.31 |